ALBT vs. ATIF, RVYL, TVGN, IKT, COEP, ONVO, GENE, CHRO, SRNE, and CELZ
Should you be buying Avalon GloboCare stock or one of its competitors? The main competitors of Avalon GloboCare include ATIF (ATIF), Ryvyl (RVYL), Tevogen Bio (TVGN), Inhibikase Therapeutics (IKT), Coeptis Therapeutics (COEP), Organovo (ONVO), Genetic Technologies (GENE), Chromocell Therapeutics (CHRO), Sorrento Therapeutics (SRNE), and Creative Medical Technology (CELZ).
Avalon GloboCare (NASDAQ:ALBT) and ATIF (NASDAQ:ATIF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, community ranking, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.
ATIF has a net margin of -1,153.75% compared to Avalon GloboCare's net margin of -1,304.14%. Avalon GloboCare's return on equity of 0.00% beat ATIF's return on equity.
1.4% of Avalon GloboCare shares are owned by institutional investors. 64.0% of Avalon GloboCare shares are owned by company insiders. Comparatively, 55.2% of ATIF shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Avalon GloboCare has a beta of 0.3, suggesting that its share price is 70% less volatile than the S&P 500. Comparatively, ATIF has a beta of -0.44, suggesting that its share price is 144% less volatile than the S&P 500.
ATIF has higher revenue and earnings than Avalon GloboCare. ATIF is trading at a lower price-to-earnings ratio than Avalon GloboCare, indicating that it is currently the more affordable of the two stocks.
ATIF received 34 more outperform votes than Avalon GloboCare when rated by MarketBeat users.
In the previous week, Avalon GloboCare had 2 more articles in the media than ATIF. MarketBeat recorded 5 mentions for Avalon GloboCare and 3 mentions for ATIF. Avalon GloboCare's average media sentiment score of 0.46 beat ATIF's score of 0.02 indicating that Avalon GloboCare is being referred to more favorably in the media.
Summary
Avalon GloboCare beats ATIF on 8 of the 14 factors compared between the two stocks.
Get Avalon GloboCare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ALBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Avalon GloboCare Competitors List
Related Companies and Tools
